Ginkgo Bioworks Holdings (DNA) EBT (2020 - 2026)
Ginkgo Bioworks Holdings (DNA) posted EBT of -$76.1 million for Q1 2026, up 6.46% on a QoQ basis from -$81.4 million in Q4 2025, and up 8.51% year-over-year from -$70.2 million in Q1 2025.
Ginkgo Bioworks Holdings (DNA) EBT (2020 - 2026) Analysis & Trends
Ginkgo Bioworks Holdings' EBT history runs 7 years deep, the most recent figure standing at -$76.1 million for Q1 2026.
- Quarterly EBT rose 8.51% year-over-year to -$76.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$298.9 million (up 35.71% YoY) and the FY2025 annual result came in at -$313.6 million, up 42.72% from the prior year.
- EBT was -$76.1 million for Q1 2026 at Ginkgo Bioworks Holdings, up from -$81.4 million in the prior quarter.
- Across five years, EBT topped out at -$56.8 million in Q3 2024 and bottomed at -$670.6 million in Q2 2022.
- A 5-year average of -$232.0 million and a median of -$173.2 million in 2023 frame the typical range for EBT.
- Peak annual rise in EBT reached 88.3% in 2022, while the deepest fall reached 1121.63% in 2022.
- Ginkgo Bioworks Holdings' EBT stood at -$187.8 million in 2022, then decreased by 12.8% to -$211.9 million in 2023, then surged by 49.1% to -$107.9 million in 2024, then gained by 24.54% to -$81.4 million in 2025, then climbed by 6.46% to -$76.1 million in 2026.
- Business Quant data shows DNA's EBT at -$76.1 million in Q1 2026, -$81.4 million in Q4 2025, and -$80.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 259.22 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.49 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 541.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Ginkgo Bioworks Holdings | 517.16 Mn | 373.30 Mn | 16.38 Mn | -76.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -76.14 Mn |
| Dec 31, 2025 | -81.39 Mn |
| Sep 30, 2025 | -80.75 Mn |
| Jun 30, 2025 | -60.58 Mn |
| Mar 31, 2025 | -83.22 Mn |
| Dec 31, 2024 | -107.86 Mn |
| Sep 30, 2024 | -56.78 Mn |
| Jun 30, 2024 | -216.99 Mn |
| Mar 31, 2024 | -165.88 Mn |
| Dec 31, 2023 | -211.89 Mn |
| Sep 30, 2023 | -302.91 Mn |
| Jun 30, 2023 | -173.25 Mn |
| Mar 31, 2023 | -204.89 Mn |
| Dec 31, 2022 | -187.85 Mn |
| Sep 30, 2022 | -670.16 Mn |
| Jun 30, 2022 | -670.62 Mn |
| Mar 31, 2022 | -592.78 Mn |
| Dec 31, 2021 | -1.61 Bn |
| Sep 30, 2021 | -102.61 Mn |
| Jun 30, 2021 | -54.90 Mn |